These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 28644037)

  • 1. Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.
    Fischer B; Russell C; Sabioni P; van den Brink W; Le Foll B; Hall W; Rehm J; Room R
    Am J Public Health; 2017 Aug; 107(8):e1-e12. PubMed ID: 28644037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update.
    Fischer B; Robinson T; Bullen C; Curran V; Jutras-Aswad D; Medina-Mora ME; Pacula RL; Rehm J; Room R; van den Brink W; Hall W
    Int J Drug Policy; 2022 Jan; 99():103381. PubMed ID: 34465496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations.
    Fischer B; Jeffries V; Hall W; Room R; Goldner E; Rehm J
    Can J Public Health; 2011; 102(5):324-7. PubMed ID: 22032094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil.
    Fischer B; Malta M; Messas G; Ribeiro M
    Braz J Psychiatry; 2019; 41(6):550-555. PubMed ID: 31116260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.
    Fischer B; Daldegan-Bueno D; Bell R; Boden JM; Bullen C; Farrell M; Hall W; Newcombe D
    Public Health Pract (Oxf); 2020 Nov; 1():100046. PubMed ID: 36101675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lower-Risk Cannabis Use Guidelines' (LRCUG) recommendations: How are Canadian cannabis users complying?
    Lee CR; Lee A; Goodman S; Hammond D; Fischer B
    Prev Med Rep; 2020 Dec; 20():101187. PubMed ID: 33083205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis.
    Russell C; Rueda S; Room R; Tyndall M; Fischer B
    Int J Drug Policy; 2018 Feb; 52():87-96. PubMed ID: 29277082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-generation antidepressants for preventing seasonal affective disorder in adults.
    Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Housing improvements for health and associated socio-economic outcomes.
    Thomson H; Thomas S; Sellstrom E; Petticrew M
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008657. PubMed ID: 23450585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue.
    Kourgiantakis T; Vicknarajah R; Logan J; Edwards T; Lee E; Craig S; Kaura A; Williams CC; Marshall S
    Subst Abuse Treat Prev Policy; 2024 Jun; 19(1):30. PubMed ID: 38886804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.
    Lutge EE; Gray A; Siegfried N
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005175. PubMed ID: 23633327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 50.